Ces radiol. 2021, 75(4):301-305 | DOI: 10.55095/CesRadiol2021/038

Isolated splenic metastasis in colorectal cancer - an example of the use of contrast ultrasonography (CEUS)Case report

David Glanc, Radim Charvát, Hynek Mírka
Klinika zobrazovacích metod LF UK a FN, Plzeň

Metastatic splenic involvement is relatively infrequent, overwhelmingly associated with extensive generalisation in other organs. The most commonly metastatic tumours to the spleen include colorectal cancer, carcinoma of lung, breast, ovary and malignant melanoma. Solitary metastatic splenic involvement is rather rare. And thus the low frequency of these findings, a diagnosis by computed tomography may not always be clear, in which case a contrast enhanced ultrasonography of the spleen offers an additional imaging method. CEUS of the spleen is a relatively simple and safe method that allows us to monitor in real time the vascularization of the lesion and surrounding parenchyma, and can thus often help distinguish between benign or malignant lesions. The case shows an exaple of a patient after resection of rectal cancer with suspected solitary metastasis of the spleen. It was the typical image on the contrast enhanced ultrasonography in this case that helped lead to the correct diagnosis, which was subsequently confirmed on the biopsy. The discussion outlines the possibilities of a contrast enhanced ultrasonography of the spleen and presents a differential diagnosis of a several most common benign and malignant spleen lesions.

Keywords: splenic metastasis, contrast ultrasonography (CUES)

Accepted: December 15, 2021; Published: December 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Glanc D, Charvát R, Mírka H. Isolated splenic metastasis in colorectal cancer - an example of the use of contrast ultrasonography (CEUS). Ces radiol. 2021;75(4):301-305. doi: 10.55095/CesRadiol2021/038.
Download citation

References

  1. Sauer J, Sobolewski K, Dommisch K. Splenic metastases - not a frequent problem, but an underestimate location of metastases: epidemiology and course. J Cancer Res Clin Oncol 2009; 135: 667-671. Go to original source... Go to PubMed...
  2. Marymont JH Jr, Gross S. Patterns of metastatic cancer in the spleen. Am J Clin Pathol 1963; 40: 58-66. Go to original source... Go to PubMed...
  3. Compe'rat E, Bardier-Dupas A, Camparo P, et al. Splenic metastases: clinicopathologic presentation, differential diagnosis, and pathogenesis. Arch Pathol Lab Med 2007; 131: 965-969. Go to original source... Go to PubMed...
  4. Piscaglia F, Bolondi L; Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006; 32: 1369-1375. Go to original source... Go to PubMed...
  5. Houdek K, Třeška V, Čertík B, Mírka H, Korčáková E, Moláček J, et al. Prvotní zkušenosti s dispenzarizací pacientů po endovaskulární léčbě výdutí břišní aorty pomocí ultrazvukového vyšetření s kontrastem. Cor Vasa 2015; 57(2): e121-126. doi: 10.1016/j.crvasa.2015.03.005 Go to original source...
  6. Zavariz JD, Konstantatou E, Deganello A, Bosanac D, Huang DY, Sellars ME, Sidhu PS. Common and uncommon features of focal splenic lesions on contrast-enhanced ultrasound: a pictorial review. Radiol Bras 2017; 50(6): 395-404. doi: 10.1590/0100-3984.2015.0209. PMID: 29307931; PMCID: PMC5746885. Go to original source... Go to PubMed...
  7. Abbott RM, Levy AD, Aguilera NS, et al. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics 2004; 24: 1137-1163. Go to original source... Go to PubMed...
  8. Townsend CM, Beauchamp RD, Evers M. Sabiston textbook of surgery: the biological basis of modern surgical practice. Philadelphia, PA: Elsevier Saunders 2012.
  9. Stang A, Keles H, Hentschke S, et al. Incidentally detected splenic lesions in ultrasound: does contrastenhanced ultrasonography improve the differentiation of benign hemangioma/hamartoma from malignant lesions? Ultraschall Med 2011; 32: 582-592. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.